U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
NYSE:USPH - New York Stock Exchange, Inc. - US90337L1089 - Common Stock
Overall USPH gets a fundamental rating of 5 out of 10. We evaluated USPH against 108 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of USPH get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, USPH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
In the past year USPH had a positive cash flow from operations.
Each year in the past 5 years USPH has been profitable.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 1.37%, USPH perfoms like the industry average, outperforming 59.81% of the companies in the same industry.
USPH has a Return On Equity of 2.92%. This is in the better half of the industry: USPH outperforms 61.68% of its industry peers.
USPH's Return On Invested Capital of 5.77% is fine compared to the rest of the industry. USPH outperforms 66.36% of its industry peers.
USPH had an Average Return On Invested Capital over the past 3 years of 6.88%. This is in line with the industry average of 8.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 2.92% | ||
| ROIC | 5.77% |
ROA(3y)3.13%
ROA(5y)4.06%
ROE(3y)7.87%
ROE(5y)9.63%
ROIC(3y)6.88%
ROIC(5y)7.92%
1.3 Margins
With a decent Profit Margin value of 2.18%, USPH is doing good in the industry, outperforming 67.29% of the companies in the same industry.
In the last couple of years the Profit Margin of USPH has declined.
USPH's Operating Margin of 10.64% is amongst the best of the industry. USPH outperforms 85.98% of its industry peers.
In the last couple of years the Operating Margin of USPH has declined.
USPH's Gross Margin of 19.41% is on the low side compared to the rest of the industry. USPH is outperformed by 63.55% of its industry peers.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.64% | ||
| PM (TTM) | 2.18% | ||
| GM | 19.41% |
OM growth 3Y-4.75%
OM growth 5Y-2.84%
PM growth 3Y-26.38%
PM growth 5Y-3.89%
GM growth 3Y-4.77%
GM growth 5Y-2.16%
2. Health
2.1 Basic Checks
USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, USPH has more shares outstanding
The number of shares outstanding for USPH has been increased compared to 5 years ago.
USPH has a better debt/assets ratio than last year.
2.2 Solvency
USPH has an Altman-Z score of 2.73. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score of 2.73. This is in the better half of the industry: USPH outperforms 61.68% of its industry peers.
USPH has a debt to FCF ratio of 1.94. This is a very positive value and a sign of high solvency as it would only need 1.94 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.94, USPH belongs to the top of the industry, outperforming 83.18% of the companies in the same industry.
USPH has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
USPH has a better Debt to Equity ratio (0.28) than 64.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 1.94 | ||
| Altman-Z | 2.73 |
ROIC/WACC0.66
WACC8.68%
2.3 Liquidity
USPH has a Current Ratio of 1.78. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of USPH (1.78) is better than 64.49% of its industry peers.
USPH has a Quick Ratio of 1.78. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.78, USPH is doing good in the industry, outperforming 67.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.78 |
3. Growth
3.1 Past
USPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.18%.
The Earnings Per Share has been decreasing by -0.61% on average over the past years.
The Revenue has grown by 9.22% in the past year. This is quite good.
The Revenue has been growing slightly by 5.91% on average over the past years.
EPS 1Y (TTM)-1.18%
EPS 3Y-3.51%
EPS 5Y-0.61%
EPS Q2Q%11.29%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y12.66%
Revenue growth 5Y5.91%
Sales Q2Q%12.02%
3.2 Future
The Earnings Per Share is expected to grow by 8.69% on average over the next years. This is quite good.
USPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.76% yearly.
EPS Next Y5.36%
EPS Next 2Y7.15%
EPS Next 3Y8.69%
EPS Next 5YN/A
Revenue Next Year10.9%
Revenue Next 2Y11.36%
Revenue Next 3Y9.76%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.74, which means the current valuation is very expensive for USPH.
USPH's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.29, USPH is valued a bit more expensive.
USPH is valuated quite expensively with a Price/Forward Earnings ratio of 30.65.
USPH's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (24.44), we can say USPH is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.74 | ||
| Fwd PE | 30.65 |
4.2 Price Multiples
USPH's Enterprise Value to EBITDA ratio is in line with the industry average.
75.70% of the companies in the same industry are more expensive than USPH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.51 | ||
| EV/EBITDA | 15.87 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.67
PEG (5Y)N/A
EPS Next 2Y7.15%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.98%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.87. USPH pays more dividend than 89.72% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
5.2 History
On average, the dividend of USPH grows each year by 13.34%, which is quite nice.
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)13.34%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 186.85% of its income as dividend. This is not a sustainable payout ratio.
USPH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP186.85%
EPS Next 2Y7.15%
EPS Next 3Y8.69%
U.S. PHYSICAL THERAPY INC
NYSE:USPH (1/21/2025, 6:40:00 PM)
After market: 90.07 0 (0%)90.07
+1.52 (+1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.3%
Inst Owner Change0.02%
Ins Owners1.49%
Ins Owner Change-1.54%
Market Cap1.36B
Analysts84.62
Price Target115.6 (28.34%)
Short Float %3.51%
Short Ratio4.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
Yearly Dividend1.72
Dividend Growth(5Y)13.34%
DP186.85%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.77%
Min EPS beat(2)-12.54%
Max EPS beat(2)-1%
EPS beat(4)1
Avg EPS beat(4)-5.48%
Min EPS beat(4)-12.54%
Max EPS beat(4)2.08%
EPS beat(8)2
Avg EPS beat(8)-2.23%
EPS beat(12)5
Avg EPS beat(12)-1.67%
EPS beat(16)9
Avg EPS beat(16)3.15%
Revenue beat(2)2
Avg Revenue beat(2)0.6%
Min Revenue beat(2)0.22%
Max Revenue beat(2)0.98%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)0.99%
Revenue beat(8)4
Avg Revenue beat(8)0.03%
Revenue beat(12)5
Avg Revenue beat(12)-0.4%
Revenue beat(16)6
Avg Revenue beat(16)-0.39%
PT rev (1m)7.94%
PT rev (3m)-0.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.23%
EPS NY rev (1m)0%
EPS NY rev (3m)7.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.74 | ||
| Fwd PE | 30.65 | ||
| P/S | 2.1 | ||
| P/FCF | 18.51 | ||
| P/OCF | 16.5 | ||
| P/B | 2.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.87 |
EPS(TTM)2.52
EY2.8%
EPS(NY)2.94
Fwd EY3.26%
FCF(TTM)4.87
FCFY5.4%
OCF(TTM)5.46
OCFY6.06%
SpS42.79
BVpS31.99
TBVpS-13
PEG (NY)6.67
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 2.92% | ||
| ROCE | 7.52% | ||
| ROIC | 5.77% | ||
| ROICexc | 6.62% | ||
| ROICexgc | 44.69% | ||
| OM | 10.64% | ||
| PM (TTM) | 2.18% | ||
| GM | 19.41% | ||
| FCFM | 11.38% |
ROA(3y)3.13%
ROA(5y)4.06%
ROE(3y)7.87%
ROE(5y)9.63%
ROIC(3y)6.88%
ROIC(5y)7.92%
ROICexc(3y)7.51%
ROICexc(5y)8.52%
ROICexgc(3y)42.22%
ROICexgc(5y)48.12%
ROCE(3y)8.97%
ROCE(5y)10.33%
ROICexcg growth 3Y-12.76%
ROICexcg growth 5Y-19.7%
ROICexc growth 3Y-7.99%
ROICexc growth 5Y-10.1%
OM growth 3Y-4.75%
OM growth 5Y-2.84%
PM growth 3Y-26.38%
PM growth 5Y-3.89%
GM growth 3Y-4.77%
GM growth 5Y-2.16%
F-Score6
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 1.94 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 52.14% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 9.42 | ||
| Cash Conversion | 95.96% | ||
| Profit Quality | 520.91% | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.78 | ||
| Altman-Z | 2.73 |
F-Score6
WACC8.68%
ROIC/WACC0.66
Cap/Depr(3y)61.98%
Cap/Depr(5y)71.88%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.72%
Profit Quality(3y)263.88%
Profit Quality(5y)249.81%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.18%
EPS 3Y-3.51%
EPS 5Y-0.61%
EPS Q2Q%11.29%
EPS Next Y5.36%
EPS Next 2Y7.15%
EPS Next 3Y8.69%
EPS Next 5YN/A
Revenue 1Y (TTM)9.22%
Revenue growth 3Y12.66%
Revenue growth 5Y5.91%
Sales Q2Q%12.02%
Revenue Next Year10.9%
Revenue Next 2Y11.36%
Revenue Next 3Y9.76%
Revenue Next 5YN/A
EBIT growth 1Y-0.26%
EBIT growth 3Y7.3%
EBIT growth 5Y2.9%
EBIT Next Year19.98%
EBIT Next 3Y14.05%
EBIT Next 5YN/A
FCF growth 1Y54.11%
FCF growth 3Y-7.68%
FCF growth 5Y2%
OCF growth 1Y44.13%
OCF growth 3Y-6.41%
OCF growth 5Y2.34%